BSE filing, BSE: 544398. Summary written from the filing by ALFA Finder's alert engine.
Kenrik Industries Ltd: key numbers
- Share price
- ₹10.97
- Market cap
- ₹13.71 Cr
- Revenue (annual)
- ₹80.20 Cr
- Net profit (annual)
- ₹0.00 Cr
- P/E (TTM)
- -3608.6×Sector 49.5×
- Promoter holding
- 72.01%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kenrik Industries Ltd
All →Kenrik Industries Other Announcement
Kenrik Industries Ltd has filed its quarterly shareholding pattern in accordance with Regulation 31(1)(b). This document provides a breakdown of equity shareholding among stakeholders.
Kenrik Industries Annual General Meeting
Kenrik Industries Limited conducted its 10th Annual General Meeting on September 29, 2026. Shareholders approved the FY 2025-26 financial statements and the reappointment of Mr. Nihar Nitinbhai Shah.
Kenrik Industries Open Offer: ₹3.25 Cr
Darsh Advisory Private Limited is making an Open Offer to acquire 26.00% (32,49,454 shares) of Kenrik Industries Limited at Rs. 10 per share.
- Value
- ₹3.25 Cr
Kenrik Industries Annual Report
Kenrik Industries Limited submitted its Annual Report for FY 2025-26 and scheduled its 10th Annual General Meeting for September 29, 2026.
Kenrik Industries Annual General Meeting
Kenrik Industries approved the Directors' Report and notice for its 10th Annual General Meeting scheduled for September 29, 2026. A Scrutinizer was also appointed.
Kenrik Industries Open Offer: ₹3.25 Cr
Kenrik Industries Ltd has announced an Open Offer by Darsh Advisory Private Limited to acquire up to 26% of the company's shares for Rs. 3.25 Crore.
- Value
- ₹3.25 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.